CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $153,000 | -90.5% | 20,000 | -89.7% | 0.00% | -88.9% |
Q4 2019 | $1,615,000 | +12.5% | 194,377 | 0.0% | 0.01% | -10.0% |
Q3 2019 | $1,435,000 | -34.2% | 194,377 | 0.0% | 0.01% | -33.3% |
Q2 2019 | $2,181,000 | +4.4% | 194,377 | 0.0% | 0.02% | +15.4% |
Q1 2019 | $2,090,000 | – | 194,377 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |